EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I Bohnen, Roger L Albin iD

Annals of Clinical and Translational Neurology · 2026

DOI: 10.1002/acn3.70335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Taylor Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Cognitive Dysfunction, Vesicular Acetylcholine Transport Proteins, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Parkinson's Foundation, NINDS NIH HHS, University of Michigan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ligand [ 18 F]‐fluoroethoxybenzovesamicol ([ 18 F]‐FEOBV) binding predicts longitudinal cognitive changes in mild–moderate, non‐demented PD subjects.

Methods

Seventy‐five non‐demented, mild–moderate PD subjects underwent baseline [ 18 F]‐FEOBV PET and standardized cognitive evaluations, with repeat cognitive testing after 2 years. Participants were classified into four cognitive classes: persistent normal (no MCI at either time point; N = 41), persistent MCI (MCI at both; N = 21), MCI conversion (normal to MCI; N = 6), and MCI reversion (MCI to normal; N = 7). We performed whole‐brain voxel comparisons (controls and between classes) and used linear and multinomial regression to predict follow‐up cognitive status.

Results

Whole‐brain voxel analyses revealed class‐specific [ 18 F]‐FEOBV binding deficits. Persistent MCI showed the most widespread reductions, extending into frontal regions. Compared with MCI reverter and persistently normal groups, persistent MCI had lower binding in occipito‐temporal and temporo‐parieto‐frontal regions, respectively, while MCI reverters showed higher occipital binding than converters. Binding in occipital, temporo‐parietal, and medial frontal regions predicted follow‐up cognitive decline, with medial frontal binding showing the strongest association (esp. global cognition, memory, and visuospatial domains).

Interpretation

Baseline cholinergic system changes associate with varying cognitive trajectories in mild–moderate PD. Assessment of regional cholinergic deficits may be useful for prediction of cognitive trajectories in this population, enhancing subject selection and stratification for intervention trials aimed at improving cognition in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCognitive DysfunctionVesicular Acetylcholine Transport ProteinsBrainHumansFemaleMaleAgedPositron-Emission TomographyMiddle AgedDisease ProgressionPiperidines

Stichwörter der Autor:innen

Parkinsonacetylcholinemild cognitive impairment

Substanzen

fluoroethoxy-benzovesamicolPiperidinesVesicular Acetylcholine Transport Proteins

Autor:innen und Institutionen

  • Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
  • Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, Michigan, USA.
  • Parkinson's Foundation Research Center of Excellence, University of Michigan, Ann Arbor, Michigan, USA.
  • Functional Neuroimaging, Cognitive, and Mobility Laboratory, Department of Radiology, Ann Arbor, MI, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
  • Neurology Service and GRECC, VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, USA.

ORCID-Profile: Roger L Albin

Förderung

  • Parkinson's Foundation
  • NINDS NIH HHS
  • University of Michigan
  • NIA NIH HHS
  • RRD VA
  • VA
  • National Institute on Aging
  • U.S. Department of Veterans Affairs

Zitieren

APA

Brown, T., Carli, G., Kanel, P., Roytman, S., Barr, J., Bohnen, N. I., & Albin, R. L. (2026). Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70335

Vancouver

Brown T, Carli G, Kanel P, Roytman S, Barr J, Bohnen NI, et al. Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70335

BibTeX
@article{Brown2026,
  author = {Brown, Taylor and Carli, Giulia and Kanel, Prabesh and Roytman, Stiven and Barr, Jaimie and Bohnen, Nicolaas I and Albin, Roger L},
  title = {Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70335}
}
Kostenlos starten →